» Articles » PMID: 8731708

Intestinal Permeability and Orocaecal Transit Time in Elderly Patients with Parkinson's Disease

Overview
Journal Postgrad Med J
Specialty General Medicine
Date 1996 Mar 1
PMID 8731708
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

The aetiology of weight loss in patients with Parkinson's disease is likely to be multifactorial. We studied 15 patients with Parkinson's disease and 15 age- and sex-matched controls and looked for evidence of malabsorption due to small bowel bacterial overgrowth or alteration of intestinal permeability. There was a marked increase in orocaecal transit time in the patients with Parkinson's disease, although lactulose hydrogen breath testing did not show evidence of small bowel bacterial contamination. Intestinal permeability measured by the differential sugar absorption test was also deranged. There was reduced absorption of mannitol in patients with Parkinson's disease while lactulose absorption was similar in both groups, suggesting decreased non-mediated uptake across the enterocyte brush border membrane in patients with Parkinson's disease.

Citing Articles

Paracellular permeability and tight junction regulation in gut health and disease.

Horowitz A, Chanez-Paredes S, Haest X, Turner J Nat Rev Gastroenterol Hepatol. 2023; 20(7):417-432.

PMID: 37186118 PMC: 10127193. DOI: 10.1038/s41575-023-00766-3.


The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment.

Varesi A, Campagnoli L, Fahmideh F, Pierella E, Romeo M, Ricevuti G Int J Mol Sci. 2022; 23(20).

PMID: 36293176 PMC: 9603886. DOI: 10.3390/ijms232012289.


Intestinal Permeability, Dysbiosis, Inflammation and Enteric Glia Cells: The Intestinal Etiology of Parkinson's Disease.

Yang H, Li S, Le W Aging Dis. 2022; 13(5):1381-1390.

PMID: 36186124 PMC: 9466983. DOI: 10.14336/AD.2022.01281.


Gastric Emptying Is Not Delayed and Does Not Correlate With Attenuated Postprandial Blood Flow Increase in Medicated Patients With Early Parkinson's Disease.

Siebner T, Fuglsang S, Madelung C, Lokkegaard A, Bendtsen F, Hove J Front Neurol. 2022; 13:828069.

PMID: 35280265 PMC: 8910363. DOI: 10.3389/fneur.2022.828069.


Safety and Tolerability, Dose-Escalating, Double-Blind Trial of Oral Mannitol in Parkinson's Disease.

Linetsky E, Abd Elhadi S, Bauer M, Gallant A, Namnah M, Weiss S Front Neurol. 2022; 12:716126.

PMID: 35046880 PMC: 8761891. DOI: 10.3389/fneur.2021.716126.


References
1.
HOEHN M, Yahr M . Parkinsonism: onset, progression and mortality. Neurology. 1967; 17(5):427-42. DOI: 10.1212/wnl.17.5.427. View

2.
DEN HARTOG JAGER W, BETHLEM J . The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry. 1960; 23:283-90. PMC: 497426. DOI: 10.1136/jnnp.23.4.283. View

3.
GIBBERD F, GLEESON J, Gossage A, Wilson R . Oesophageal dilatation in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1974; 37(8):938-40. PMC: 494808. DOI: 10.1136/jnnp.37.8.938. View

4.
Ohama E, Ikuta F . Parkinson's disease: distribution of Lewy bodies and monoamine neuron system. Acta Neuropathol. 1976; 34(4):311-9. DOI: 10.1007/BF00696560. View

5.
Metz G, Gassull M, Drasar B, Jenkins D, Blendis L . Breath-hydrogen test for small-intestinal bacterial colonisation. Lancet. 1976; 1(7961):668-9. DOI: 10.1016/s0140-6736(76)92779-3. View